CSIMarket
 


Atara Biotherapeutics Inc   (ATRA)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare

Atara Biotherapeutics Inc 's Leverage Ratio

ATRA's quarterly Leverage Ratio and Total Liabilities, Equity growth




ATRA Leverage Ratio (Jun 30 2020)
II. Quarter
(Mar 31 2020)
I. Quarter
(Dec 31 2019)
IV. Quarter
(Sep 30 2019)
III. Quarter
(Jun 30 2019)
II. Quarter
Y / Y Equity Change 64.08 % -10.96 % -14.19 % -20.99 % -48.67 %
Y / Y Total Liabilities Change 12.23 % 14.54 % 54.45 % 28.43 % 24.8 %
Leverage Ratio MRQ 0.12 0.18 0.18 0.15 0.18
Overall Ranking # # # # #
Seq. Equity Change 50.75 % -13.05 % -8.69 % 37.09 % -18.19 %
Seq. Total Liabilities Change 0.56 % -10.42 % 12.55 % 10.7 % 2.63 %



Leverage Ratio second quarter 2020 Comment
Despite net new borrowings of 0.56% Atara Biotherapeutics Inc managed to improve Leverage Ratio in the second quarter 2020 to 0.12, above company's average Leverage Ratio.

Within Biotechnology & Drugs industry in the second quarter 2020, 40 other companies have achieved lower Leverage Ratio than Atara Biotherapeutics Inc . While total ranking remained unchanged compare to previous quarter at no. .

Explain Leverage Ratio?
Who are ATRA Customers?
Leverage Ratio second quarter 2020 Company Ranking
Within: No.
Biotechnology & Drugs Industry # 41
Healthcare Sector # 118
Overall Market # 236


Leverage Ratio Statistics
High Average Low
0.2 0.09 0.02
(Dec 31 2017)  




Financial Statements
Atara Biotherapeutics Inc 's Equity $ 381 Millions Visit ATRA's Balance sheet
Atara Biotherapeutics Inc 's Total Liabilities $ 47 Millions Visit ATRA's Balance sheet
Source of ATRA's Sales Visit ATRA's Sales by Geography




Companies with similar Leverage Ratio in the quarter endingJun 30 2020, within Biotechnology & Drugs Industry Leverage RatioJun 30 2020 MRQ Total LiabilitiesJun 30 2020 MRQ Equity
Citius Pharmaceuticals Inc   0.34 $ 9.658  Millions$ 28.742  Millions
Phathom Pharmaceuticals Inc   0.33 $ 62.253  Millions$ 188.423  Millions
Momenta Pharmaceuticals inc   0.32 $ 127.962  Millions$ 395.317  Millions
Atyr Pharma Inc  0.32 $ 11.462  Millions$ 35.938  Millions
Repligen Corp  0.31 $ 338.048  Millions$ 1,100.027  Millions
Syndax Pharmaceuticals Inc   0.30 $ 44.981  Millions$ 147.647  Millions
Beam Therapeutics Inc   0.30 $ 69.153  Millions$ 230.822  Millions
Eyenovia Inc   0.29 $ 2.427  Millions$ 8.319  Millions
Denali Therapeutics Inc   0.29 $ 145.170  Millions$ 502.167  Millions
Anavex Life Sciences Corp   0.28 $ 6.949  Millions$ 24.681  Millions
Surface Oncology Inc   0.28 $ 27.163  Millions$ 97.671  Millions
Frequency Therapeutics Inc   0.27 $ 43.085  Millions$ 161.701  Millions
Cue Biopharma Inc   0.26 $ 21.199  Millions$ 80.154  Millions
Spero Therapeutics Inc   0.26 $ 19.208  Millions$ 73.714  Millions
Adaptimmune Therapeutics Plc  0.26 $ 104.616  Millions$ 407.585  Millions
Bluebird Bio Inc   0.25 $ 425.759  Millions$ 1,682.031  Millions
Scpharmaceuticals Inc   0.25 $ 24.708  Millions$ 98.059  Millions
G1 Therapeutics Inc   0.24 $ 49.752  Millions$ 203.845  Millions
Xenetic Biosciences Inc   0.24 $ 3.706  Millions$ 15.358  Millions
Pdl Biopharma Inc   0.24 $ 100.188  Millions$ 420.001  Millions
Zymeworks Inc   0.24 $ 115.600  Millions$ 491.253  Millions
Eidos Therapeutics Inc   0.22 $ 33.066  Millions$ 149.311  Millions
Cytrx Corp  0.21 $ 2.765  Millions$ 12.864  Millions
Seattle Genetics Inc  0.19 $ 350.479  Millions$ 1,814.077  Millions
Pharmacyte Biotech Inc   0.19 $ 1.187  Millions$ 6.245  Millions
Cardiff Oncology inc   0.18 $ 4.438  Millions$ 24.384  Millions
Pds Biotechnology Corp  0.18 $ 3.079  Millions$ 17.014  Millions
Capricor Therapeutics Inc   0.17 $ 5.472  Millions$ 31.654  Millions
Akers Biosciences Inc   0.16 $ 2.626  Millions$ 15.972  Millions
Vir Biotechnology Inc   0.16 $ 92.392  Millions$ 563.779  Millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

JCP's Profile

Stock Price

JCP's Financials

Business Description

Fundamentals

Charts & Quotes

JCP's News

Suppliers

JCP's Competitors

Customers & Markets

Economic Indicators

JCP's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2020 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071